Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy.
Ma S, Seymour JF, Brander DM, Kipps TJ, Choi MY, Anderson MA, Humphrey K, Al Masud A, Pesko J, Nandam R, Salem AH, Chyla B, Arzt J, Jacobson A, Kim SY, Roberts AW.
Ma S, et al. Among authors: al masud a.
Blood. 2021 Sep 9;138(10):836-846. doi: 10.1182/blood.2020009578.
Blood. 2021.
PMID: 34115103
Free PMC article.
Clinical Trial.